Metsa Board Oyj B (METSB)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 3.100 |
|---|---|
| 52-week range | 2.512 – 3.622 |
| Return, 1 month / 3 months | −10.8% / +8.7% |
| Return, 1 year / 3 years | +16.4% / −57.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 0.86M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Metsä Board Oyj is a Finnish producer of fresh fibre paperboard and paper made from wood pulp. The company supplies folding boxboard, white kraftliner and related paper grades used for consumer packaging, food service and graphic applications. Its customers are converters, brand owners and packaging companies in Europe and other markets, and its mills and headquarters are in Finland. The business sits within the Metsä Group forest industry cooperative.
Metsa Board Oyj B trades under the code METSB on the Helsinki Exchange in Finland, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Metsa Board Oyj B (METSB) trades on the Helsinki Exchange in Finland. It last closed at EUR 3.100 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 35 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.4% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -13.9% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 6.7% | ||
| 12-month return, skipping the last month | 30.5% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 0.86M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −10.8% |
| 3 months | +8.7% |
| 6 months | +6.7% |
| 1 year | +16.4% |
| 3 years | −57.4% |
| 5 years | −56.3% |
Signals
| 50-day / 200-day average | 3.331 / 3.012 |
|---|---|
| Golden / death cross (60 days) | Golden, 44 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Mar 2025 | EUR 0.0700 |
| 27 Mar 2024 | EUR 0.2500 |
| 24 Mar 2023 | EUR 0.5800 |
| 25 Mar 2022 | EUR 0.4100 |
| 26 Mar 2021 | EUR 0.1000 |
| 12 Jun 2020 | EUR 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.